Literature DB >> 23052389

Overlapping structure of hepatitis B virus (HBV) genome and immune selection pressure are critical forces modulating HBV evolution.

Valeria Cento1, Carmen Mirabelli1, Salvatore Dimonte1, Romina Salpini1, Yue Han2, Pascale Trimoulet3, Ada Bertoli4, Valeria Micheli5, Guido Gubertini5, Giuseppina Cappiello6, Alberto Spanò6, Roberta Longo6, Martina Bernassola6, Francesco Mazzotta7, Giuseppe Maria De Sanctis8, Xin Xin Zhang2, Jens Verheyen9, Antonella D'Arminio Monforte10, Francesca Ceccherini-Silberstein1, Carlo Federico Perno1, Valentina Svicher1.   

Abstract

How the overlap between the hepatitis B virus (HBV) reverse transcriptase (RT) and HBV S antigen (HBsAg) genes modulates the extent of HBV genetic variability is still an open question, and was investigated here. The rate of nucleotide conservation (≤1% variability) followed an atypical pattern in the RT gene, due to an overlap between RT and HBsAg (69.9% nucleotide conservation in the overlapping region vs 41.2% in the non-overlapping region; P<0.001), with a consequently lower rate of synonymous substitution within the overlapping region [median(interquartile range)dS=3.1(1.5-7.4) vs 20.1(10.6-30.0); P=3.249×10(-22)]. The most conserved RT regions were located within the YMDD motif and the N-terminal parts of the palm and finger domains, critical for RT functionality. These regions also corresponded to highly conserved HBsAg domains that are critical for HBsAg secretion. Conversely, the genomic region encoding the HBsAg antigenic loop (where immune-escape mutations are localized) showed a sharp decrease in the extent of conservation (40.6%), which was less pronounced in the setting of human immunodeficiency virus (HIV)-driven immune suppression (48.8% in HIV-HBV co-infection vs 21.5% in mono-infected patients; P=0.020). In conclusion, the overlapping reading frame and the immune system appear to have shaped the patterns of RT and HBsAg genetic variability. Highly conserved regions in RT and HBsAg may deserve further attention as novel therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23052389     DOI: 10.1099/vir.0.046524-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Less is more: an adaptive branch-site random effects model for efficient detection of episodic diversifying selection.

Authors:  Martin D Smith; Joel O Wertheim; Steven Weaver; Ben Murrell; Konrad Scheffler; Sergei L Kosakovsky Pond
Journal:  Mol Biol Evol       Date:  2015-02-19       Impact factor: 16.240

2.  Simulation of B cell affinity maturation explains enhanced antibody cross-reactivity induced by the polyvalent malaria vaccine AMA1.

Authors:  Sidhartha Chaudhury; Jaques Reifman; Anders Wallqvist
Journal:  J Immunol       Date:  2014-07-30       Impact factor: 5.422

3.  Detection of hepatitis B virus isolates with mutations associated with immune escape mutants among pregnant women in Ibadan, southwestern Nigeria.

Authors:  Temitope Oluwasegun Cephas Faleye; Moses Olubusuyi Adewumi; Ijeoma Maryjoy Ifeorah; Ewean Chukwuma Omoruyi; Solomon Adeleye Bakarey; Adegboyega Akere; Funmilola Awokunle; Hannah Opeyemi Ajibola; Deborah Oluwaseyi Makanjuola; Johnson Adekunle Adeniji
Journal:  Springerplus       Date:  2015-02-01

Review 4.  Insights From Deep Sequencing of the HBV Genome-Unique, Tiny, and Misunderstood.

Authors:  Anna L McNaughton; Valentina D'Arienzo; M Azim Ansari; Sheila F Lumley; Margaret Littlejohn; Peter Revill; Jane A McKeating; Philippa C Matthews
Journal:  Gastroenterology       Date:  2018-09-27       Impact factor: 22.682

Review 5.  A meta-analysis on genetic variability of RT/HBsAg overlapping region of hepatitis B virus (HBV) isolates of Bangladesh.

Authors:  Md Golzar Hossain; Keiji Ueda
Journal:  Infect Agent Cancer       Date:  2019-11-07       Impact factor: 2.965

6.  Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength.

Authors:  Monique T A de Beijer; Diahann T S L Jansen; Yingying Dou; Wim J E van Esch; Juk Yee Mok; Mariëlle J P Maas; Giso Brasser; Robert A de Man; Andrea M Woltman; Sonja I Buschow
Journal:  J Virol       Date:  2020-03-17       Impact factor: 5.103

7.  Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations.

Authors:  Jolynne Mokaya; Tetyana I Vasylyeva; Eleanor Barnes; M Azim Ansari; Oliver G Pybus; Philippa C Matthews
Journal:  J Viral Hepat       Date:  2021-05-07       Impact factor: 3.517

Review 8.  Molecular Mechanisms during Hepatitis B Infection and the Effects of the Virus Variability.

Authors:  Marina Campos-Valdez; Hugo C Monroy-Ramírez; Juan Armendáriz-Borunda; Laura V Sánchez-Orozco
Journal:  Viruses       Date:  2021-06-18       Impact factor: 5.048

9.  Evolution and structural organization of the C proteins of paramyxovirinae.

Authors:  Michael K Lo; Teit Max Søgaard; David G Karlin
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

10.  In silico Analysis of Genetic Diversity of Human Hepatitis B Virus in Southeast Asia, Australia and New Zealand.

Authors:  Ngoc Minh Hien Phan; Helen Faddy; Robert Flower; Kirsten Spann; Eileen Roulis
Journal:  Viruses       Date:  2020-04-09       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.